| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Touchstone Center for Diabetes Research, Department of Internal Medicine, University of Texas Southwestern Medical Center and Veterans Affairs Medical Center, Dallas, TX, USA
* To whom correspondence should be addressed. E-mail: May-yun.Wang{at}UTSouthwestern.edu.
In obese rodents excess myocardial lipid accumulation (lipotoxicity) of myocardium may cause cardiomyopathy that in the obese ZDF fa/fa rat can be prevented by treatment with troglitazone (TGZ). To determine the underlying mechanisms we measured total 5'- AMP-activated kinase (AMPK) protein and its activated, phosphorylated form, P-AMPK. P-AMPK was significantly reduced in both ZDF fa/fa rat and ob/ob mouse hearts compared to lean, wild-type controls. TGZ treatment of obese ZDF rats, which lowered cardiac lipid content, increased P-AMPK. Expression of protein phosphatase 2C (PP2C), which inactivates AMPK activity by dephosphorylation, was increased in untreated ZDF fa/fa rat hearts, but fell with TGZ treatment, suggesting that PP2C can influence AMPK activity. In cultured myocardiocytes fatty acids reduced P-AMPK, suggesting a feed-forward effect of lipid overload. Our findings highlight a role of PP2C and AMPK in the derangements of cardiac lipid metabolism in obesity and provide new insights as to the mechanisms of the liporegulatory disorder leading to lipotoxic cardiomyopathy.
This article has been cited by other articles:
|
|
 |
|
  H. Ma, J. Li, F. Gao, and J. Ren Aldehyde Dehydrogenase 2 Ameliorates Acute Cardiac Toxicity of Ethanol: Role of Protein Phosphatase and Forkhead Transcription Factor J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2187 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Bobulescu, M. Dubree, J. Zhang, P. McLeroy, and O. W. Moe Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1419 - F1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, J. Li, and J. Ren UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E965 - E973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Rabkin and P. Lodha Stearic acid-induced cardiac lipotoxicity is independent of cellular lipid and is mitigated by the fatty acids oleic and capric acid but not by the PPAR agonist troglitazone Exp Physiol, August 1, 2009; 94(8): 877 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sironi, A. Pingitore, S. Ghione, D. De Marchi, B. Scattini, V. Positano, E. Muscelli, D. Ciociaro, M. Lombardi, E. Ferrannini, et al. Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat Hypertension, February 1, 2008; 51(2): 282 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Ruberg Myocardial Lipid Accumulation in the Diabetic Heart Circulation, September 4, 2007; 116(10): 1110 - 1112. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley Cardiac Energy Metabolism in Obesity Circ. Res., August 17, 2007; 101(4): 335 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Guo, T. Pirtskhalava, T. Tchkonia, W. Xie, T. Thomou, J. Han, T. Wang, S. Wong, A. Cartwright, F. G. Hegardt, et al. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1041 - E1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zang, S. Xu, K. A. Maitland-Toolan, A. Zuccollo, X. Hou, B. Jiang, M. Wierzbicki, T. J. Verbeuren, and R. A. Cohen Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor-Deficient Mice. Diabetes, August 1, 2006; 55(8): 2180 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lessard, Z.-P. Chen, M. J. Watt, M. Hashem, J. J. Reid, M. A. Febbraio, B. E. Kemp, and J. A. Hawley Chronic rosiglitazone treatment restores AMPK{alpha}2 activity in insulin-resistant rat skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E251 - E257. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
